Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Net profit of Gufic BioSciences declined 37.34% to Rs 13.07 crore in the quarter ended June 2025 as against Rs 20.86 crore during the previous quarter ended June 2024. Sales rose 10.31% to Rs 223.72 crore in the quarter ended June 2025 as against Rs 202.81 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales223.72202.81 10 OPM %14.8817.64 - PBDT24.9932.41 -23 PBT17.2728.10 -39 NP13.0720.86 -37 Powered by Capital Market - Live News

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live News

Gufic BioSciences has appointed Rajesh Kaul as Senior President � Sparsh Cluster, Senior Management Personnel of the Company with effect from 04 July 2025. Powered by Capital Market - Live News

Net profit of Gufic BioSciences declined 61.50% to Rs 7.72 crore in the quarter ended March 2025 as against Rs 20.05 crore during the previous quarter ended March 2024. Sales rose 5.14% to Rs 205.02 crore in the quarter ended March 2025 as against Rs 194.99 crore during the previous quarter ended March 2024.For the full year,net profit declined 19.14% to Rs 69.65 crore in the year ended March 2025 as against Rs 86.14 crore during the previous year ended March 2024. Sales rose 1.63% to Rs 819.81 crore in the year ended March 2025 as against Rs 806.67 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales205.02194.99 5 819.81806.67 2 OPM %12.8717.55 -16.4318.08 - PBDT18.3731.46 -42 115.21132.69 -13 PBT10.5227.12 -61 94.14115.67 -19 NP7.7220.05 -61 69.6586.14 -19 Powered by Capital Market - Live News